19. Pathogen Genomics Center

Yokoyama M, Huang YL, Hasegawa A, Shioda T, Sato H,Kannagi M, Masuda T. Critical Contribution of Tyr15 in1)

Y. Torii, T. Fujii, I. Kukimoto, M. Saito, T. Iwata, H.

the HIV-1 Integrase (IN) to Facilitate the IN Assembly

Takahashi, R. Ichikawa, S. Kawai, S. Otani, and D. Aoki.

and Non-enzymatic Function Through the IN Precursor

Comparison of methods using paraffin-embedded tissues

Formand exfoliated cervical cells to evaluate human

91:e02003-16, 2017.

papillomavirus genotype attribution. Cancer Science,2)

4)

5)

6)

7)

J.

Virol.,

10) Sato H, Yokoyama M, Nakamura H, Oka T, Katayama K,

S. Mori, T. Takeuchi, Y. Ishii, T. Yugawa, T. Kiyono, H.

Evolutionary constraints on the norovirus pandemic

Nishina, and I. Kukimoto. Human Papillomavirus 16 E6

variant GII.4_2006b over the five-year persistence inUpregulates APOBEC3B via the TEAD Transcription

Japan. Front. Microbiol., 8:410, 2017.

N,NodaM,TanakaT,MotomuraK.

11) Tsutsui R, Tsukagoshi H, Nagasawa K, Takahashi M,Miyatake H, Sanjoh A, Murakami T, Murakami H,

Matsushima Y, Ryo A, Kuroda M, Takami H, Kimura H.

Matsuda G, Hagiwara K, Yokoyama M, Sato H,

Genetic analyses of the fusion protein genes in human

Miyamoto Y, Dohmae N, Aida Y. Molecular mechanism

parainfluenza virus types 1 and 3 among patients withof HIV-1 Vpr for binding to importin-α. J. Mol. Biol.,acute respiratory infections in Eastern Japan from 2011

428:2744-57, 2016.

to 2015. J Med Microbiol. 2017 Feb;66(2):160-168.

Hikichi Y, Yokoyama M, Takemura T, Fujino M,12) Hamada H, Sekizuka T, Oba K, Katano H, Kinumaki A,Kumakura S, Maeda Y, Yamamoto N, Sato H, Matano T,Terai M, Mizutani T, Kuroda M. Comprehensive

Murakami T. Increased HIV-1 Sensitivity to Neutralizing

pathogen detection associated with four recurrent

Antibodies by Mutations in The Env V3-Coding Region

episodes of Kawasaki disease in a patient during a single

for Resistance to CXCR4 Antagonists. J. Gen. Virol.,year using next-generation sequencing. JMM Case Rep.

97:2427-40, 2016.

2016 Feb 1;3(1):e005019.

Haga K, Fujimoto A, Takai-Todaka R, Miki M, Yen DH,13) Imamura D, Morita M, Sekizuka T, Mizuno T, Takemura

Murakami K, Yokoyama M, Murata K, Nakanishi A,T,Katayama K. Functional receptor molecules CD300lf

Mukhopadhyay AK, Ramamurthy T, Miyoshi SI, Kuroda

and CD300ld enable murine norovirus to internalize into

M, Shinoda S, Ohnishi M. Comparative genome analysis

host cells. Proc. Natl. Acad. Sci. USA., 113:E6248-55,of VSP-II and SNPs reveals heterogenic variation in2016.

contemporary strains of Vibrio cholerae O1 isolated from

Kotani O, Suzuki T, Yokoyama M, Iwata-Yoshikawa N,

cholera patients in Kolkata, India. PLoS Negl Trop Dis.

Nakajima N, Sato H, Hasegawa H, Taguchi F, Shimizu H,

2017 Feb 13;11(2):e0005386.

Yamashiro

T,

ChowdhuryG,

Pazhani

GP,Nagata N. Intracerebral inoculation of mouse-passaged14) Segawa T, Matsui M, Suzuki M, Tsutsui A, Kuroda M,

Saffold virus type 3 affects cerebellar development inShibayama K, Suzuki S. Utilizing the Carba NP test asneonatal mice. J. Virol., 90:10007–21, 2016.

an indicator of expression level of carbapenemase genes

Alam M, Kuwata T, Shimura K, Yokoyama M, Ramirez

in Enterobacteriaceae. J Microbiol Methods. 2017

Valdez KP, Tanaka K, Maruta Y, Oishi S, Fujii N, Sato H,Feb;133:35-39.

Enhanced15) Kurai D, Sasaki Y, Saraya T, Ishii H, Tsukagoshi H,

antibody‑mediated neutralization of HIV‑1 variants that

Kozawa K, Ryo A, Ishioka T, Kuroda M, Oishi K,

are resistant to fusion inhibitors. Retrovirology, 13:70,Takizawa H, Kimura H. Pathogen profiles and molecular2016.

epidemiology

Sakuragi S, Yokoyama M, Shioda T, Sato H, Sakuragi J.

inpatients with community-acquired pneumonia. Respir

SL1 revisited: functional analysis of the structure andInvestig. 2016 Jul;54(4):255-63.

M,MatsushitaS.

conformation of HIV‑1 genome RNA. Retrovirology,
9)

Transcriptase.

TakedaMatsuoka

8)

Reverse107:1520-1526 (2016)

Factor. Journal of Virology, 91:e02413-16 (2017)3)

withofrespiratory

virusesinJapanese16) Sakamoto K, Sekizuka T, Uehara T, Hishima T, Mine S,

13:79, 2016.

Fukumoto H, Sato Y, Hasegawa H, Kuroda M, Katano H.

Takahata T, Takeda E, Tobiume M, Tokunaga K,

Next-generation sequencing of miRNAs in clinicalsamplesof

Epstein-Barrvirus-associatedB-cell

Fujita K, Yoshida LM, Tanaka R, Ishii H, Shimojo N,lymphomas. Cancer Med. 2017 Mar;6(3):605-618.

Kuroda M, Ryo A. Molecular evolution of the fusion17) Hasegawa N, Sekizuka T, Sugi Y, Kawakami N,

protein gene in human respiratory syncytial virus

Ogasawara Y, Kato K, Yamashita A, Takeuchi F, Kuroda

subgroup A. Infect Genet Evol. 2016 Sep;43:398-406.

of25) Shimizu H, Arai K, Abe J, Nakabayashi K, Yoshioka T,

Streptococcus intermedius TYG1620 Isolated from a

Hosoi K, Kuroda M. Repeated fecal microbiota

Human Brain Abscess Based on the Complete Genometransplantation in a child with ulcerative colitis. Pediatr

Sequence with Transcriptome Analysis and Transposon

Int. 2016 Aug;58(8):781-5.

M.

CharacterizationofthePathogenicity

Mutagenesis in a Murine Subcutaneous Abscess Model.
Infect Immun. 2017 Jan 26;85(2). pii:e00886-16.

26) Takajo I, Sekizuka T, Fujita H, Kawano A, Kawaguchi T,Matsuda M, Kubo K, Miyauchi S, Umekita K, Nagatomo18) Kawanishi M, Abo H, Ozawa M, Uchiyama M,Y, Kuroda M, Takasaki T, Okayama A, Ando S. Possible

Shirakawa T, Suzuki S, Shima A, Yamashita A, Sekizuka

Case of Novel Spotted Fever Group Rickettsiosis inT, Kato K, Kuroda M, Koike R, Kijima M. Prevalence ofTraveler Returning to Japan from India. Emerg InfectColistin Resistance Gene mcr-1 and Absence of mcr-2 in

Dis. 2016 Jun;22(6):1079-82.

Escherichia coli Isolated from Healthy Food-Producing27) Kobayashi M, Matsushima Y, Motoya T, Sakon N,Animals in Japan. Antimicrob Agents Chemother. 2016

Shigemoto N, Okamoto-Nakagawa R, Nishimura K,

Dec 27;61(1). pii: e02057-16.

Yamashita Y, Kuroda M, Saruki N, Ryo A, Saraya T,19) Takahashi K, Sekizuka T, Fukumoto H, Nakamichi K,

Morita Y, Shirabe K, Ishikawa M, Takahashi T,Suzuki T, Sato Y, Hasegawa H, Kuroda M, Katano H.

Shinomiya H, Okabe N, Nagasawa K, Suzuki Y,Deep-Sequence

Virus

Katayama K, Kimura H. Molecular evolution of theReplication of a JC Virus Quasispecies in Patients withcapsid gene in human norovirus genogroup II. Sci Rep.

Progressive Multifocal Leukoencephalopathy. J Virol.

2016 Jul 7;6:29400.

IdentificationandRolein28) Fukumoto H, Hishima T, Hasegawa H, Saeki H, Kuroda

2016 Dec 16;91(1). pii: e01335-16.
20) Hoshina S, Sekizuka T, Kataoka M, Hasegawa H,M, Katano H. Evaluation of Vero-cell-derived simian

Hamada H, Kuroda M, Katano H. Profile of Exosomal

endogenous retrovirus infection in humans by detection

andinof viral genome in clinicopathological samples andGamma-Herpesvirus-Infected Lymphoma Cell Lines.

commercialized vaccines and by serology of Japanese

PLoS One. 2016 Sep 9;11(9):e0162574.

generalIntracellularmicroRNA21) Osawa M, Mine S, Ota S, Kato K, Sekizuka T, Kuroda

population.

Vaccine.

2016May23;34(24):2700-6.

M, Kataoka M, Fukumoto H, Sato Y, Kanno T,29) Maruyama C, Niikura H, Izumikawa M, Hashimoto J,Hasegawa H, Ueda K, Fukayama M, Maeda T, Kanoh S,Shin-Ya K, Komatsu M, Ikeda H, Kuroda M, Sekizuka T,Kawana A, Fujikura Y, Katano H. Establishing andIshikawa

characterizing a new primary effusion lymphoma cell

Aminoacylation of an Amino Sugar Intermediate in theline harboring Kaposi's sarcoma-associated herpesvirus.

Biosynthesis of a Streptothricin-Related Antibiotic. Appl

Infect Agent Cancer. 2016 Aug 17;11:37.

Environ Microbiol. 2016 May 31;82(12):3640-8.

J,HamanoY.

tRNA-Dependent22) Yamashita A, Sakamoto T, Sekizuka T, Kato K, Takasaki30) Akiba M, Sekizuka T, Yamashita A, Kuroda M, Fujii Y,T, Kuroda M. DGV: Dengue Genographic Viewer. Front

Murata M, Lee K, Joshua DI, Balakrishna K, Bairy I,

Microbiol. 2016 Jun 7;7:875.

Subramanian K, Krishnan P, Munuswamy N, Sinha RK,23) Nakayama E, Kotaki A, Tajima S, Kawada M, Miura K,

Iwata T, Kusumoto M, Guruge KS. Distribution andGemma A, Adachi T, Sekizuka T, Kato K, Yamashita A,Relationships of Antimicrobial Resistance Determinants

Moi ML, Ikeda M, Yagasaki K, Shibasaki K, Saijo M,

among Extended-Spectrum-Cephalosporin-Resistant orKuroda M, Takasaki T. Two different dengue virus

Carbapenem-Resistant Escherichia coli Isolates fromstrains in the Japanese epidemics of 2014. Virus Genes.

RiversandSewage

2016 Oct;52(5):722-6.

Antimicrob

Agents24) Kimura H, Nagasawa K, Tsukagoshi H, Matsushima Y,

22;60(5):2972-80.

Treatment

PlantsChemother.

inIndia.

2016Apr31) Yamashita A, Sekizuka T, Kuroda M. VirusTAP: Viral
Genome-Targeted Assembly Pipeline. Front Microbiol.
2016 Feb 2;7:32.
32) Kobayashi M, Matsushima Y, Motoya T, Sakon N,Shigemoto N, Okamoto-Nakagawa R, Nishimura K,
Yamashita Y, Kuroda M, Saruki N, Ryo A, Saraya T,Morita Y, Shirabe K, Ishikawa M, Takahashi T,
Shinomiya H, Okabe N, Nagasawa K, Suzuki Y,
Katayama K, Kimura H. Molecular evolution of thecapsid gene in human norovirus genogroup II. Sci Rep.
2016 Jul 7;6:29400.
33) Suzuki S, Ohnishi M, Kawanishi M, Akiba M, Kuroda M.
Investigation of a plasmid genome database forcolistin-resistance gene mcr-1. Lancet Infect Dis. 2016
Mar;16(3):284-5.
34) Devault AM, Mortimer TD, Kitchen A, Kiesewetter H,Enk JM, Golding GB, Southon J, Kuch M, Duggan AT,Aylward W, Gardner SN, Allen JE, King AM, Wright G,Kuroda M, Kato K, Briggs DE, Fornaciari G, Holmes EC,Poinar HN, Pepperell CS. A molecular portrait ofmaternal sepsis from Byzantine Troy Elife. 2017 Jan
10;6: e20983.